Understanding the body's response to leptospirosis for better diagnosis
Treatments studied
Part of Infections clinical trials.
This study looks at how your body responds to leptospirosis, a bacterial infection spread by animals, to improve diagnosis and treatment. It compares people with leptospirosis, those with other infections, and healthy individuals to find better ways to detect the disease early.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be able to give written consent and have social security coverage.
- For the fever groups: You need a fever above 38°C (100.4°F) and symptoms like muscle aches or headache that suggest leptospirosis.
- If you have leptospirosis, you'll be confirmed by lab tests like PCR or other standard methods.
- Alternatively, you may join if you have a different acute infection (bacterial, dengue, Zika, or respiratory virus) that is confirmed by lab tests.
- Healthy volunteers are also welcome if you have no fever and no infection symptoms in the last 28 days.
- You cannot join if you have a chronic inflammatory disease, are pregnant, or have been hospitalized recently.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how your blood cells react to the bacteria that cause leptospirosis, and tests a new treatment that may help your immune system fight the infection better.
This trial tests a structured set of hospital treatments (“care bundle”) for adults with suspected leptospirosis, a serious infection often linked to flood water exposure. It may help by improving how quickly and consistently key care steps are delivered in the hospital.
This trial tests ways to prevent early and late complications of leptospirosis, a bacterial infection. It aims to offer treatments that may reduce the risk of serious problems like kidney failure or breathing difficulties.
This study records information from people who have invasive (spreading) leptospirosis, a bacterial infection. The goal is to better understand how the disease presents and spreads, which can help improve future care.
This study checks whether workers in Montpellier's zoo, green spaces, or Ecolothèque have been exposed to germs from animals. It uses a blood test to look for past infections, which may help protect workers in similar jobs.
This study tests whether taking an antibiotic, doxycycline, can help prevent leptospirosis, a bacterial infection you can get from water or soil that may be contaminated by animal urine. If you've been exposed to risky environments, this trial aims to see if the medicine can stop you from getting sick.
Hear when a new Leptospirosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.